Vancouver, British Columbia, April 6, 2022 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life”, “Juva” or “Company”), A life sciences company engaged in pharmaceutical research and development and consumer business in cannabis production and distribution, its subsidiary, Juva Retail RWC Inc, today operates a retail cannabis storefront on 2301 Broadway in Redwood City, British Columbia. Has been licensed to retail. Juva has been granted one of four approvals to permit over-the-counter retail cannabis business in commercial and multipurpose zones, following a rigorous and competitive application process.
Doug Crowpek, CEO and Founder of Juba, said: “Juva Retail Stores is a business milestone that we’ve been strategically working on for nearly two years. The same five-star service and best-in-class, known to offer through JuvaDelivery at new store locations. We look forward to providing our products to our customers. “
Redwood City has a four-stage cannabis program developed with community support after the state legalized the sale of adult cannabis in 2016. Interviews, further scoring, and Phase IV were the final city manager choices for the selected companies.
This process involves a rigorous staff-led merit-based application to ensure that high-quality retail cannabis operators are thoroughly reviewed and qualified prior to obtaining a permit. Was there. All cannabis over-the-counter retail applications had to provide relevant information such as neighborhood compatibility, security and security plans, and community profit plans.
Juva Retail RWC Inc. was the highest overall applicant with a total of 1,876 points in Phase III. This, combined with our Phase II score of 1,196 points, is equivalent to 3,072 points, for a total score of 96%.
In addition, Juva Life continues to focus on pharmaceutical and life sciences research, working to identify the mechanism of action behind the anecdotal ability of cannabis to control pain and inflammation. We recently identified the non-cannabinoid compounds JUVA-019 and JUVA-041, applied for patents, conducted preclinical studies, and these compounds suppress inflammation by regulating specific biomarkers in the body. It has been shown to be effective as a stand-alone compound. .. JUVA-019 and JUVA-041, which we have designated as key drug candidates for further preclinical studies, are currently advancing through phenotypic models of age-related chronic diseases.
On behalf of the board
Doug Chloupek, CEO and Founder
Juba Life Co., Ltd.
About Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRA: 4VV)
Juva Life employs state-of-the-art pharmaceutical research and development to discover, develop and commercialize safe and effective cannabis products. The company leverages interdisciplinary research professionals across different disciplines of cultivation, extraction and formulation standardization to provide consumers with reproducible medical benefits. Juva builds on these natural product process chemistry skills and incorporates discovery pharmacology through a validated discovery technology platform. We will leverage the revenue generated from our retail business to advance JUVA-019, JUVA-041, and other potentially valuable non-cannabinoid bioactive substances for consumer and pharmaceutical applications. Juva is working to bring the cannabis market to the next generation of investment-eligible business models in this sector. For more information, please visit https://juvalife.com/.
For more information, please contact:
Juba Life Investor Relations
Tel: Tel: +1 833-333-5882 (JUVA)
Description of future prospects
This news release contains statements and information that may constitute “forward-looking information” in the sense of applicable securities law, unless it is a historical fact. Forward-looking information may include statements about financial and other forecasts, as well as future plans, objectives, or financial performance, or the assumptions underlying any of the above. In some cases, forward-looking statements may be “may,” “do,” “can,” “do,” “probably,” “exception,” “anticipate,” “believe,” and “. It can be identified by terms such as “intended”. , “Plan”, “Forecast”, “Project”, “Estimate”, “Forecast”, or their negative expressions, or other similar expressions for matters that are not historical facts. Examples of such statements include, but are not limited to, statements regarding our objectives and business plans. Product development, commercialization strategies and future collaboration.
Forward-looking information includes known and unknown risks, uncertainties, and future results, performance, or performance that express or imply our actual results, performance, or performance by the information about the future. Includes other factors that may differ significantly from. Risks associated with our future business plans. The risk that we will not be able to retain key personnel. Described in the discussions and analysis of our management for the fiscal year ended December 31, 2020 under the heading “Risks and Uncertainties”, as well as the risks that we cannot secure under reasonable conditions or at all. All other risks that have been. Therefore, readers should not place excessive reliance on such forward-looking information. In addition, forward-looking information is provided only as of the date on which such statements were made. New factors emerge from time to time, and our management anticipates all of such factors and proactively assesses the impact of each such factor on our business, or any factor, or a combination of factors. That is impossible. , Actual results may differ materially from those contained in the forward-looking information. Unless required by law, including securities law, we provide forward-looking information to reflect information or events after the date it was created, or to reflect the occurrence of an unexpected event. We do not undertake any obligation to renew.
CSE is not responsible for the validity or accuracy of this release.
Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b4ba6c99-6b8f-4f5c-875e-f8bf029b13b7.
CBJ News Maker
Juva Life has licensed its first retail cannabis store in Redwood City, California. CanadianBusiness Journal
Source link Juva Life has licensed its first retail cannabis store in Redwood City, California. CanadianBusiness Journal